South Africa SAHPRA Medical Device Registration Guide (2026): Complete Process, Fees, Timeline & Requirements

Overview of South Africa's Medical Device Market

South Africa is the largest medical device market on the African continent and serves as a gateway to Sub-Saharan Africa. The country's medical device market is valued at approximately $1–2 billion (2025), driven by a dual public-private healthcare system, growing chronic disease burden, and increasing healthcare expenditure. South Africa is a member of the IMDRF (International Medical Device Regulators Forum) and is progressively building a comprehensive regulatory framework under the South African Health Products Regulatory Authority (SAHPRA).

SAHPRA was established in 2018 under the Medicines and Related Substances Act, 1965 (Act 101 of 1965) to replace the former Medicines Control Council (MCC). SAHPRA regulates medicines, medical devices, IVDs, and cosmetics. For medical devices, SAHPRA is currently in a transitional phase — establishment licensing is mandatory, but full product registration is being rolled out in phases.

This guide covers what is required today and what is coming so you can plan your South African market entry strategy.

Regulatory Framework

Key Legislation

Regulation	Purpose	Status
Medicines and Related Substances Act 101 of 1965	Primary legal framework for health products regulation	In effect
General Regulations (Government Gazette 1379, Dec 2020)	Establishment licensing fees and requirements	In effect
SAHPRA Medical Device Guidelines (GLF-MD series)	Application forms, licensing procedures, classification rules	In effect, regularly updated
SAHPGL-MD-04: Classification of Medical Devices and IVDs (Feb 2025, v5)	Classification rules for all device types	In effect
SAHPGL-MD-22: Medical Devices Reliance Guideline (Feb 2026)	Reliance pathways for product registration using foreign approvals	Published Feb 2026
SAHPGL-MD-21: Certificate of Free Sale for Medical Devices (Mar 2026)	Requirements for obtaining certificates of free sale	Published Mar 2026
SAHPGL-MD-16: Clinical Evaluation of Medical Devices (Sep 2025)	Clinical evaluation requirements	In effect
SAHPGL-MD-03: Adverse Event Reporting (Dec 2024, v4)	Vigilance and adverse event reporting obligations	In effect
SAHPGL-MD-18: Post Market Surveillance and PMCF (Sep 2025)	PMS and post-market clinical follow-up requirements	In effect
SAHPGL-MD-17: Clinical Investigation of Medical Devices (Sep 2025)	Clinical trial requirements for medical devices	In effect
Medical Devices Registration Feasibility Study (Mar 2026)	Framework for phased product registration roll-out	Published Mar 2026
ISO 13485 Phase-In Requirements (Sep 2025)	Phased mandate for ISO 13485 certification by establishment type	Phased through April 2028

Regulatory Authority

SAHPRA (South African Health Products Regulatory Authority) — under the National Department of Health. SAHPRA's Medical Devices Unit handles:

• Establishment licensing (mandatory — manufacturing, distribution, import/export, wholesale)
• Product registration (phased roll-out in progress)
• Post-market surveillance and vigilance
• Regulatory inspections
• Radiation Control licensing (for radiation-emitting devices)

Device Classification

South Africa uses the IMDRF-aligned, four-tier classification system:

Class	Risk Level	Examples
Class A	Low risk	Non-sterile bandages, wheelchair accessories, manual surgical instruments
Class B	Low to moderate risk	Syringes, surgical gloves, blood pressure monitors
Class C	Moderate to high risk	Ventilators, bone implants, diagnostic X-ray equipment
Class D	High risk	Heart valves, pacemakers, implantable neurostimulators

Classification is based on factors including:

• Invasiveness (invasive vs. non-invasive)
• Duration of contact with the body (transient, short-term, long-term)
• Intended use (diagnosis, treatment, monitoring, life-support)
• Impact on individual and public health (especially for IVDs)

Manufacturers are responsible for classifying their devices according to SAHPRA's classification rules, which align with IMDRF principles.

Establishment Licensing (Mandatory)

What Is an Establishment Licence?

A Medical Device Establishment Licence from SAHPRA is mandatory for any company that manufactures, imports, exports, distributes, or wholesales medical devices in South Africa. No medical device may be manufactured, distributed, imported, exported, or sold without a valid SAHPRA establishment licence.

Types of Establishment Licences

Licence Type	Activities Covered	Fee (New Application)
Manufacturer	Manufacture, pack, label, service, import, export	ZAR 25,200 (~$1,400)
Distributor	Import, export, distribute	ZAR 15,000 (~$830)
Wholesaler	Storage, transportation, delivery	ZAR 15,000 (~$830)
Import only	Import	ZAR 15,000 (~$830)
Export only	Export	ZAR 15,000 (~$830)

Licence Renewal and Annual Fees

Item	Manufacturer	Distributor/Wholesaler
Renewal fee (every 5 years)	ZAR 22,000 (~$1,220)	ZAR 12,600 (~$700)
Annual retention fee	ZAR 4,200 (~$230)	ZAR 4,200 (~$230)
Amendment fee	ZAR 5,300 (~$290)	ZAR 5,300 (~$290)
Licence issuance fee	ZAR 3,400 (~$190)	ZAR 3,400 (~$190)

Licence Validity

• SAHPRA establishment licence: Valid for 5 years; annual retention fee must be paid each June
• Radiation Control licence: Valid indefinitely; annual written confirmation (every September) required that the CE certificate is still valid

Exemptions

Non-sterile, non-measuring Class A medical devices are exempt from establishment licensing requirements, per SAHPRA's position statement on Class A medical devices.

Authorized Representative Requirement

Medical device establishments that have applied for a SAHPRA licence must appoint an Authorized Representative who must be a natural person based in South Africa. One representative is required for each site where the company carries out its business. The representative is responsible for adherence to the law, regulations, and guidelines.

ISO 13485 Requirements (Phased Mandate)

SAHPRA is phasing in ISO 13485:2016 certification as a mandatory requirement for all medical device establishments. The phased rollout follows this timeline:

Phase	Effective Date	Requirement
Phase 1	Until April 2025	Preparation and sensitization period; stakeholder engagement
Phase 2	June 1, 2025	ISO 13485 required upon licence renewal
Phase 3	April 1, 2026	All existing licence holders must submit ISO 13485 certificates for verification
Phase 4	June 1, 2027	ISO 13485 required for all licence amendments and product-list updates
Phase 5	April 1, 2028	All new applications must include ISO 13485:2016 certificate

Key point: As of April 2026, every existing licence holder must have an ISO 13485 certificate available for SAHPRA verification during audits, product-complaint investigations, or vigilance activities.

Product Registration (Phased Roll-Out)

Current Status (April 2026)

SAHPRA's product registration process for medical devices is still in development. Key facts:

• Product registration is not yet fully enforced for all device classes
• A Registration Call-Up Plan will be published to specify which devices are prioritized
• A pilot registration feasibility study began in May 2024 for selected high-risk devices and IVDs (including HIV/TB tests)
• The feasibility study report was updated in March 2026

Reliance Pathway (SAHPGL-MD-22, Feb 2026)

SAHPRA's Medical Devices Reliance Guideline (SAHPGL-MD-22), published February 2026, establishes a reliance-oriented registration model. SAHPRA will leverage approvals from recognized stringent regulatory authorities:

Recognized Reference Authorities:

• US FDA
• European Union (CE marking under MDR/IVDR)
• Australia (TGA)
• Japan (PMDA/MHLW)
• Health Canada
• Brazil (ANVISA)
• WHO Prequalification (for IVDs)

How Reliance Works for Product Registration

For Class B, C, and D devices, SAHPRA uses a hybrid model:

1. Standard dossier aligned with SAHPRA guidelines (MD-09 for IVDs, MD-10 for non-IVDs)
2. Evidence of approval from a recognized reference authority streamlines the review
3. Products with WHO prequalification or approval from multiple stringent authorities receive expedited processing
4. Products without any reference authority approval require full dossiers and longer review times

Registration Validity (Planned)

Once product registration becomes mandatory:

• Marketing Authorization Certificate expected to be valid for 5 years
• Renewal applications required before expiry
• Variation applications for changes to manufacturing site, labeling, etc.

Required Documentation

For Establishment Licensing

Document	Requirement
Company registration documents	Required
Business registration certificate / incorporation documents	Required
Authorized Representative appointment letter	Required
List of all medical devices to be handled (with GMDN codes)	Required
QMS declaration (ISO 13485 certification by renewal phase)	Required
Facility details (storage, handling capabilities)	Required
Proof of payment of applicable fees	Required

For Product Registration (When Applicable)

Document	Class A/B	Class C/D
Classification documentation	Required	Required
Technical documentation	Required	Required
ISO 13485 certificate for manufacturing site	Required	Required
Foreign regulatory approval (if available)	Recommended	Required for reliance pathway
Free Sale Certificate	Recommended	Required
Clinical data	Not typically required	Required for higher-risk devices
Risk analysis	Recommended	Required
Labeling in English	Required	Required

Step-by-Step Registration Process

Step 1 — Classify Your Device

Determine the risk class (A–D) following SAHPRA's IMDRF-aligned classification rules.

Step 2 — Establish a Local Entity or Appoint an Authorized Representative

Foreign manufacturers must have a South African-based entity or authorized representative. The AR must be a natural person based in South Africa.

Step 3 — Obtain Establishment Licence

• Complete the relevant SAHPRA application form (GLF-MD-06 series)
• Submit with required documentation and proof of payment
• Processing timeline: 6–8 weeks (regular pathway); 10–15 working days (expedited, limited cases)

Step 4 — Comply with ISO 13485 Requirements

Based on your phase:

• If renewing: submit ISO 13485 certificate with renewal application
• If existing licence holder (from April 2026): have certificate available for verification
• If applying new (from April 2028): include ISO 13485 in initial application

Step 5 — Register Products (When Called Up)

• Monitor SAHPRA's Registration Call-Up Plan
• Prepare dossier using SAHPRA guidelines (MD-09 for IVDs, MD-10 for non-IVDs)
• Leverage reliance pathway if you have approvals from recognized reference authorities
• Submit through SAHPRA's digital platform (under development)

Step 6 — Post-Market Compliance

• Maintain annual retention fee payments
• Submit annual compliance information (ASOCI) for electromedical devices
• Comply with vigilance and adverse event reporting requirements
• Maintain ISO 13485 certification

AI/ML-Enabled Medical Devices

SAHPRA published a communication in September 2025 (Issue No. MD08-2025/2026) establishing regulatory requirements for AI/ML-enabled medical devices:

• All AI/ML-enabled devices require authorization from SAHPRA before marketing
• Classification follows the same four-tier system (Class A–D)
• Establishment licence is required even before formal product registration is called up
• Manufacturers must demonstrate compliance with existing medical device regulations including QMS requirements

Radiation Control Requirements

Medical devices that emit radiation (X-ray equipment, MRI, ultrasound with specific outputs) require an additional Radiation Control Licence from SAHPRA's Radiation Control department. Since the Radiation Control Department became part of SAHPRA, there is now a single submission for both the SAHPRA licence and Radiation Control licence, although two separate licences are issued.

Additional requirements may apply for electronic products listed under the Schedule for Listed Electronic Products Regulation R1302 of 1991.

Common Challenges and How to Avoid Them

1. Not Having an Establishment Licence

Operating without a SAHPRA establishment licence is illegal. Apply early — processing takes 6–8 weeks.

2. Missing ISO 13485 Certification

From April 2026, existing licence holders must have ISO 13485 available for verification. Start your certification process now if you haven't already.

3. Incorrect Classification

SAHPRA follows IMDRF classification rules. Misclassification can delay your application. When in doubt, classify conservatively or seek regulatory advice.

4. Not Having a Local Authorized Representative

Foreign manufacturers must appoint a South African-based AR. This must be a natural person, not just a corporate entity.

5. Waiting for Full Product Registration

While product registration is not yet fully enforced, establishment licensing is. Secure your establishment licence now so you're ready when the call-up plan is published.

6. Not Leveraging Reference Country Approvals

SAHPRA's reliance pathway rewards manufacturers with approvals from FDA, CE, TGA, PMDA, Health Canada, or ANVISA. Having these approvals significantly streamlines future product registration.

Total Cost Estimate

Cost Item	Estimated Range
Establishment licence (Manufacturer — new)	~$1,400
Establishment licence (Distributor — new)	~$830
Annual retention fee	~$230/year
Authorized Representative fees (annual)	$2,000–$8,000
ISO 13485 certification (if not already held)	$5,000–$15,000
Regulatory consultant (establishment licensing)	$3,000–$10,000
Document preparation and translation	$1,000–$5,000
Total estimated cost (first year)	$13,000–$40,000

Key Takeaways

• Establishment licensing is mandatory now — product registration is being phased in
• SAHPRA uses a reliance model — approvals from FDA, CE, TGA, PMDA, Health Canada, and ANVISA are recognized
• ISO 13485 is becoming mandatory — phased through April 2028; existing holders must have it by April 2026
• Classification follows IMDRF principles — four-tier system (Class A–D)
• Authorized Representative must be a natural person in South Africa — one per site
• Establishment licence is valid for 5 years with annual retention fees
• Non-sterile, non-measuring Class A devices are exempt from licensing
• Budget 6–8 weeks for establishment licence processing
• Budget $13,000–$40,000 total for first year including all costs
• AI/ML devices require SAHPRA authorization even before formal product registration
• Monitor the Registration Call-Up Plan for product registration timelines

2026 Regulatory Updates You Should Know

ISO 13485 Phase 3 Takes Effect (April 2026)

From April 1, 2026, all existing SAHPRA licence holders must have ISO 13485:2016 certificates available for verification. SAHPRA may request proof during audits, product-complaint investigations, or vigilance activities. Ensure your certification is current and covers the exact manufacturing sites listed in your SAHPRA licence.

Medical Devices Reliance Guideline (SAHPGL-MD-22, Feb 2026)

Published in February 2026, this guideline formalizes SAHPRA's reliance pathways for product registration. It specifies how SAHPRA will leverage approvals from recognized stringent regulatory authorities (FDA, CE, TGA, PMDA, Health Canada, ANVISA, WHO PQ). The guideline creates a hybrid model that still expects robust documentation but rewards applicants with trusted foreign approvals.

Registration Feasibility Study Updated (March 2026)

SAHPRA published an updated Medical Devices Registration Feasibility Study report in March 2026. This report supports the implementation of a comprehensive risk-based registration framework. It evaluates approaches for phased registration of medical devices and IVDs, including both locally manufactured and legally imported products.

Annual Submission of Compliance Information (ASOCI)

SAHPRA has formalized the annual compliance submission process for licence holders importing electromedical devices. Licence holders are divided into 8 alphabetical groups, with monthly email notifications starting April 1 each year. Companies have 30 working days to submit completed compliance spreadsheets, and SAHPRA has 60 working days to finalize processing.

AI/ML Medical Device Requirements

SAHPRA's September 2025 communication establishes that all AI/ML-enabled medical devices (including stand-alone software and those integrated into hardware) require SAHPRA authorization. Classification follows the standard Class A–D system. The guidance was developed with input from PATH, Clinton Health Access Initiative, UK CERSI-AI, and major technology companies.

Frequently Asked Questions

How long does it take to get a SAHPRA establishment licence?

Standard processing takes 6–8 weeks. An expedited pathway exists for certain cases (10–15 working days).

Is product registration currently required?

Not yet for all devices. Establishment licensing is mandatory. Product registration is being rolled out in phases — a Registration Call-Up Plan will specify when different device classes must register. A pilot feasibility study is underway for high-risk devices and IVDs.

Which countries' approvals does SAHPRA recognize?

US FDA, EU CE marking, Australia TGA, Japan PMDA/MHLW, Health Canada, Brazil ANVISA, and WHO Prequalification for IVDs.

Do I need ISO 13485?

Yes, increasingly. For licence renewals from June 2025. For all existing licence holders from April 2026 (verification). For amendments from June 2027. For all new applications from April 2028.

Is local testing required?

No. SAHPRA does not currently require local testing of medical devices. However, additional licensing may be required for electronic products listed under Regulation R1302 of 1991.

Can I transfer my licence to another company?

No. Licence transfer is not possible in South Africa. The acquiring company must submit a new application.

Does South Africa require UDI?

UDI requirements are being developed as part of the broader product registration framework. Monitor SAHPRA communications for implementation timelines.

What are the post-market obligations?

Adverse event reporting is mandatory. Licence holders must pay annual retention fees. ASOCI annual compliance submissions are required for electromedical device importers. ISO 13485 must be maintained throughout the licence period.